Method for the determination of plasmin .alpha.2 -antiplasmin complexes and the use of this method as a mean of determining changes in the fibrinolytic system
US5587291A · kind A · utility
7Cited by
3References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 10, 1993 |
| Grant date | Dec 24, 1996 |
| Priority date | — |
| Expiry date | Dec 10, 2013 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/968
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Method for the quantitative determination of plasmin-.alpha.2-antiplasmin complexes, using a specific monoclonal antibody directed against the neoantigene in the plasmin-.alpha.2-antiplasmin complex, and use of such a method of determining PAP-complexes in plasma and serum to assess changes in the fibrinolytic potential.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.